People who are pregnant or nursing, have active cancer, are managing chronic illness, or are recovering from major medical procedures should avoid experimental peptide use unless specifically advised by a qualified healthcare professional
Pharmacological risks : Even if the product is genuine, the adverse effect profile of retatrutide as observed in the published phase 2 clinical trial includes nausea, vomiting, diarrhoea, decreased appetite, and injection-site reactions
Shop Now 2017 - Revive Begins BUILT FROM THE GROUND UP Before RAW, there was a vision
Trends Cancer 2 , 295304 (2016)
Fras JP, Davies MJ, Rosenstock J, et al
Springer, London Eiserich JP, van der Vliet A, Handelman GJ, Halliwell B, Cross CE (1995) Dietary antioxidants and cigarette smoke-induced biomolecular damage: a complex interaction